FONDARED 7.5MG INJECTION contains fondaparinux which belongs to the group of medicines called Anti-thrombotic agents. It is used to manage deep vein thrombosis and pulmonary embolism in adults, manage the formation of blood clots in the blood vessels of the legs or lungs after orthopedic surgery or abdominal surgery and manage some types of heart attack and severe angina (pain caused by narrowing of the arteries in the heart) and to manage blood clots in blood vessels that are near the surface of the skin of the legs (superficial vein thrombosis).
Deep vein thrombosis occurs when a blood clot (thrombus) forms in one or more of the deep veins in the body, usually in the legs. Deep vein thrombosis can cause leg pain or swelling and can occur with no symptoms. Pulmonary embolism (PE) is a blood clot that develops in a blood vessel in the body (often in the leg) and then travels to a lung artery where it suddenly blocks blood flow to the artery of the lungs.
FONDARED 7.5MG INJECTION is not recommended for use in patients having bacterial heart infection, very severe kidney disease or are bleeding excessively. Before receiving FONDARED 7.5MG INJECTION, inform your doctor if you have the risk of uncontrolled bleeding (hemorrhage) including stomach ulcer, bleeding disorders, recent bleeding into the brain (intracranial bleeding), recent surgery on the brain, spine or eye or severe liver disease.
FONDARED 7.5MG INJECTION is not recommended to use among pregnant or breastfeeding women. Consult your doctor before receiving it. FONDARED 7.5MG INJECTION should be used with caution in elderly patients above 75 years of and is not recommended for use in children below 17 years of age.
The most common side effects of receiving FONDARED 7.5MG INJECTION are bleeding from an operation site, an existing stomach ulcer, nosebleed and bruising. Consult your doctor if any of the symptoms worsen.
No content available
